Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences

Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences

Diğer sürümleri göster (1)

The heterogeneity of renal cell carcinoma (RCC) poses a challenge for designing clinically applicable diagnostic and screening investigations, predictive and prognostic biomarkers, and targeted molecular therapies. Hereditary RCC syndromes harbor specific driver gene mutations, and their discoveries...

Detaylı Bibliyografya
Asıl Yazarlar:	Yang, O, Maxwell, P, Pollard, P
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences.
Yazar:: Yang, O, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
Yazar:: Yi Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
Yazar:: Petra Miikkulainen, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Metabolic reprogramming of clear cell renal cell carcinoma
Yazar:: Haiyan Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
Yazar:: Ion Alexandru Bobulescu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.
Yazar:: Gathercole, L, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics
Yazar:: Lei Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
Yazar:: Christofer Rupert, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
Yazar:: Yuetong Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Cholesterol metabolism related-intermediates and genes in clear cell renal cell carcinoma
Yazar:: D. Loizzo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Abnormal cholesterol metabolism in renal clear cell carcinoma
Yazar:: R L Gebhard, ve diğerleri
Baskı/Yayın Bilgisi: (1987-10-01)

Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
Yazar:: Hui Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
Yazar:: Yongli Situ, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
Yazar:: Alessandra Scagliola, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation
Yazar:: Bo Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Yazar:: Philipp Seidel, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
Yazar:: Bin Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Diagnostic and therapeutic aspects of recurrent renal stone disease
Yazar:: Anthony Meyers, ve diğerleri
Baskı/Yayın Bilgisi: (1998-01-01)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma
Baskı/Yayın Bilgisi: (2013-01-01)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma.
Yazar:: Christel Häggström, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

542 TIGIT as a potential therapeutic target in renal cell carcinoma
Yazar:: Mario Sznol, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Research Progress on Ferroptosis as a Therapeutic Strategy in Renal Cell Carcinoma
Yazar:: Minna Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma
Yazar:: Rebeca Osca-Verdegal, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
Yazar:: Jin Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma
Yazar:: Yuxia Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

In vitro evidence for a new therapeutic approach in renal cell carcinoma
Yazar:: Carmine Pittoggi, ve diğerleri
Baskı/Yayın Bilgisi: (2008-08-01)

Editorial: Interplay Between Autophagy and Metabolic Syndrome: Causes, Consequences and Therapeutic Challenges
Yazar:: Stephen F. Rodrigues, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

[Translated article] Spiny Keratoderma as a Paraneoplastic Condition in Clear Cell Renal Cell Carcinoma
Yazar:: L. Linares-Gonzalez, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects
Yazar:: Naoto Kuroda, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

AURKB affects the proliferation of clear cell renal cell carcinoma by regulating fatty acid metabolism
Yazar:: Yang Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
Yazar:: Johansson, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
Yazar:: Yanyu Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking
Yazar:: Maria F. Czyzyk-Krzeska, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Yazar:: Renate Pichler, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
Yazar:: Jun Teishima, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
Yazar:: Yue Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Re: In vitro evidence for a new therapeutic approach in renal cell carcinoma
Yazar:: Corrado Spadafora
Baskı/Yayın Bilgisi: (2009-04-01)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
Yazar:: Yali Cheng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Metabolic and nutritional aspects in continuous renal replacement therapy
Yazar:: Guy Fishman, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Ultrastructural changes in renal parenchyma with renal cell carcinoma
Yazar:: S. Pasichnyk, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)